TELA director Neels files initial Form 3

TELA Bio, Inc. director Guido J. Neels filed an initial insider ownership report on Form 3.

Rhea-AI Filing Summary

TELA Bio, Inc. director Guido J. Neels filed an initial insider ownership report on Form 3. This filing establishes his status as a director and is a baseline regulatory disclosure. The data provided shows no reported purchases, sales, or other transactions in TELA Bio securities.

Key Figures

Buy transactions: 0 Sell transactions: 0 Net shares bought or sold: 0 shares

3 metrics

Buy transactions 0 buyCount in transaction summary

Sell transactions 0 sellCount in transaction summary

Net shares bought or sold 0 shares netBuySellShares in transaction summary

Key Terms

reporting person, ten percent owner, derivative transaction

3 terms

reporting person regulatory

""reportingPersons": [ { "name": "NEELS GUIDO J""

ten percent owner regulatory

""is_ten_percent_owner": 0"

derivative transaction financial

""derivativeTransactionCount": 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TELA (TELA) Form 3 filed by Guido J. Neels show?

The Form 3 identifies Guido J. Neels as a director of TELA Bio, Inc. It serves as an initial insider ownership report and, in the data provided, shows no buy, sell, or other securities transactions.

Did Guido J. Neels buy or sell TELA (TELA) shares in this Form 3?

No transactions are reported in this Form 3. The transaction summary lists zero buys, sells, exercises, gifts, tax withholdings, or restructurings, indicating only an initial disclosure of insider status.

What insider role is disclosed for Guido J. Neels at TELA (TELA)?

The filing shows Guido J. Neels is a director of TELA Bio, Inc. He is not listed as an officer and is not marked as a ten percent owner in the provided data fields.

Does the TELA (TELA) Form 3 include derivative securities activity?

No derivative activity is shown in the supplied data. The derivativeTransactionCount and related exercise fields are zero, and the derivative summary is empty, indicating no reported option or similar transactions.

What does a netBuySellDirection of neutral mean in the TELA (TELA) Form 3?

The netBuySellDirection is listed as neutral with netBuySellShares of zero. This reflects that the Form 3 data includes no net buying or selling activity, only the initial insider reporting information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 06:08 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

NEELS GUIDO J

(Last) (First) (Middle)

C/O TELA BIO, INC.

1 GREAT VALLEY PARKWAY, SUITE 24

(Street)

MALVERN PENNSYLVANIA 19355

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Megan Smeykal, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)